Your browser doesn't support javascript.
loading
Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT.
Zhao, Yan-Yan; Jia, Jing; Zhang, Jing-Jing; Xun, Yan-Ping; Xie, Shu-Jun; Liang, Jia-Feng; Guo, Hong-Gang; Zhu, Jia-Zhen; Ma, Sheng-Lin; Zhang, Shi-Rong.
Afiliación
  • Zhao YY; Department of Translation Medicine Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
  • Jia J; Center for Molecular Medicine, Zhejiang Academy of Medical Sciences, Hangzhou, 310006, China.
  • Zhang JJ; Department of Translation Medicine Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
  • Xun YP; Department of Translation Medicine Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
  • Xie SJ; Department of Translation Medicine Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
  • Liang JF; Department of Translation Medicine Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
  • Guo HG; Center for Molecular Medicine, Zhejiang Academy of Medical Sciences, Hangzhou, 310006, China.
  • Zhu JZ; College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 310006, China.
  • Ma SL; Department of Translation Medicine Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China. mashenglin@medmail.com.cn.
  • Zhang SR; Department of Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China. mashenglin@medmail.com.cn.
Acta Pharmacol Sin ; 42(8): 1288-1297, 2021 Aug.
Article en En | MEDLINE | ID: mdl-33159174
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Histamínicos H3 / Sistema de Señalización de MAP Quinasas / Transición Epitelial-Mesenquimal / Antagonistas de los Receptores Histamínicos / Imidazoles / Antineoplásicos Límite: Humans Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Histamínicos H3 / Sistema de Señalización de MAP Quinasas / Transición Epitelial-Mesenquimal / Antagonistas de los Receptores Histamínicos / Imidazoles / Antineoplásicos Límite: Humans Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China